학술논문
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
Document Type
Article
Author
Phillips, Andrew N ; Venter, Francois; Havlir, Diane; Pozniak, Anton; Kuritzkes, Daniel; Wensing, Annemarie; Lundgren, Jens D; De Luca, Andrea; Pillay, Deenan; Mellors, John; Cambiano, Valentina; Bansi-Matharu, Loveleen; Nakagawa, Fumiyo; Kalua, Thokozani; Jahn, Andreas; Apollo, Tsitsi; Mugurungi, Owen; Clayden, Polly; Gupta, Ravindra K; Barnabas, Ruanne; Revill, Paul; Cohn, Jennifer; Bertagnolio, Silvia; Calmy, Alexandra
Source
In The Lancet HIV February 2019 6(2):e116-e127
Subject
Language
ISSN
2352-3018